Atlas Trials

Treatment of Mild-moderate Clostridium Difficile Infection (CDI)

Clinical trial NCT04121169 · UNKNOWN

Trial details

NCT number
NCT04121169
Sponsor
ImmuniMed Inc.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Clostridium Difficile Infection (CDI)
Start date
2019-10-04
Primary completion
2023-12-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.